James Andrea S. (CIK 2027010) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-30). Recent activity: Buy IMDX (28,302 shares), Sell IMDX (11,298 shares), Buy IMDX (50,000 shares), Sell IMDX (12,175 shares), Buy IMDX (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | Buy | 28,302 | $0 |
| 2026-03-30 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | Sell | 11,298 | $46,435 |
| 2025-11-13 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | Buy | 50,000 | $0 |
| 2025-11-13 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | Sell | 12,175 | $73,172 |
| 2025-11-04 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | Buy | 50,000 | $0 |
| 2025-02-11 | Oncocyte Corp (OCX) | Chief Financial Officer | Buy | 97,561 | $200,000 |
Source: SEC Form 4 filings · as of 2026-03-30